These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16447035)

  • 1. [Long QT syndrome and anaesthesia].
    Rasche S; Koch T; Hübler M
    Anaesthesist; 2006 Mar; 55(3):229-46. PubMed ID: 16447035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sevoflurane-associated torsade de pointes in a patient with congenital long QT syndrome genotype 2.
    Kumakura M; Hara K; Sata T
    J Clin Anesth; 2016 Sep; 33():81-5. PubMed ID: 27555138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of anesthesia on cardiac repolarization.
    Owczuk R; Wujtewicz MA; Zienciuk-Krajka A; Lasińska-Kowara M; Piankowski A; Wujtewicz M
    Minerva Anestesiol; 2012 Apr; 78(4):483-95. PubMed ID: 22318402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes during sevoflurane anesthesia in a child with congenital long QT syndrome.
    Saussine M; Massad I; Raczka F; Davy JM; Frapier JM
    Paediatr Anaesth; 2006 Jan; 16(1):63-5. PubMed ID: 16409532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: a versatile in vivo model in cardiovascular safety research.
    Van Deuren B; Van Ammel K; Somers Y; Cools F; Straetemans R; van der Linde HJ; Gallacher DJ
    J Pharmacol Toxicol Methods; 2009; 60(1):11-23. PubMed ID: 19422925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary acetylcholine-induced prolongation of the QT interval and Torsade des Pointes in long QT interval syndrome.
    Aizawa Y; Matsubara T; Higuchi K; Washizuka T; Tamura Y; Uchiyama H; Igarashi Y; Shibata A
    Jpn Heart J; 1994 Sep; 35(5):683-8. PubMed ID: 7830332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long QT syndromes and torsade de pointes.
    Viskin S
    Lancet; 1999 Nov; 354(9190):1625-33. PubMed ID: 10560690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ECG pearl: acquired long QT syndrome].
    Tomcsányi J; Tomcsányi K
    Orv Hetil; 2018 Sep; 159(39):1607-1610. PubMed ID: 30543125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT and TdP. QT: an unreliable predictor of proarrhythmia.
    Hondeghem LM
    Acta Cardiol; 2008 Feb; 63(1):1-7. PubMed ID: 18372573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital Long QT syndrome and torsade de pointes.
    El-Sherif N; Turitto G; Boutjdir M
    Ann Noninvasive Electrocardiol; 2017 Nov; 22(6):. PubMed ID: 28670758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Torsade de pointes: a new way to kill drugs].
    Tamargo Menéndez LJ
    An R Acad Nac Med (Madr); 1998; 115(1):23-42; discussion 42-6. PubMed ID: 9741134
    [No Abstract]   [Full Text] [Related]  

  • 16. Long QT syndrome and anaesthesia.
    Booker PD; Whyte SD; Ladusans EJ
    Br J Anaesth; 2003 Mar; 90(3):349-66. PubMed ID: 12594150
    [No Abstract]   [Full Text] [Related]  

  • 17. SEVOFLURANE AS A CAUSE OF TORSADE DE POINTES IN PATIENT WITH THE LONG QT SYNDROME: Case Report.
    Choromanski DW; Amin S; Zestos MM
    Middle East J Anaesthesiol; 2016 Feb; 23(4):471-4. PubMed ID: 27382818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired long QT syndrome and torsade de pointes.
    El-Sherif N; Turitto G; Boutjdir M
    Pacing Clin Electrophysiol; 2018 Apr; 41(4):414-421. PubMed ID: 29405316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.